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Abstract
Netrins are secreted molecules involved in axon guidance and angiogenesis. We previously showed that Netrin-4
acts as an anti-angiogenic factor by inhibiting endothelial cell (EC) functions. In this study, we investigated the
effects of Netrin-4 on vascular smooth muscle cell (VSMC) activity in vitro and in vivo. We show that exogenous
Netrin-4 stimulated VSMC adhesion and migration, and increased their coverage on EC tubes (grown on a Matrigel
substrate). siRNA knock-down of endogenous Netrin-4 expression in VSMC decreased their recruitment to EC tubes.
VSMC expressed Netrin-4 and three of the six Netrin-1 cognate receptors: DCC, Neogenin, and Unc5B. Silencing of
these receptors reduced Netrin-4 adhesion to VSMC, strongly suggesting that these receptors were involved in the
recruitment process. We previously showed that Netrin-4 overexpression in PC3 cancer cells delayed tumor growth
in a model of subcutaneous xenograft by reducing tumor vessel density. Here, we show that Netrin-4
overexpression improved tumor blood vessel structure and increased VSMC coverage. Thus, Netrin-4 induced mural
cell recruitment may play a role in the inhibition of tumor growth. Our data suggest that Netrin-4 is important for
blood vessel normalization through the regulation of both endothelial and perivascular cells.
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Introduction
The integrity of the blood vessel network requires recipro-
cal interactions between endothelial cells (EC) and associ-
ated perivascular cells (referred to as pericytes, vascular
smooth muscle cells (VSMC) or mural cells). EC form the
inner lining of the vessel wall and perivascular cells envelop
the surface of the vascular tube [1]. During angiogenesis,
newly formed blood vessels become stabilized through the
recruitment of vascular mural cells. Interactions between
EC and mural cells in the blood vessel may be important
in the regulation of vascular formation, stabilization, re-
modeling and function. Failure of these interactions
during development results in severe or lethal vascular
defects. Diseases such as diabetes and tumor angiogenesis
result from abnormal interactions between the two cell
types [2,3]. The role of EC in these interactions has been
extensively studied, whereas the importance of pericyte
coverage in blood vessel maturation has only been dem-
onstrated more recently [1-4]. Pericyte coverage may limit
tumor cell metastasis [5,6]. Therefore, it is possible that
factors inhibiting angiogenesis not only reduce EC func-
tions, but also stimulate pericyte coverage.
Originally identified as axonal guidance molecules,
Netrins are laminin-like secreted proteins involved in
angiogenesis and blood vessel network formation [7-10].
The Netrin system comprises of at least five ligands
(Netrin 1, 2, 4, G1a, G1b) and six receptors (Neogenin,
DCC, Unc5A, B, C and D) [11]. As observed in nervous
system axonal guidance, Netrins act as bi-functional cues
for angiogenesis; however, the role of Netrins within the
vasculature remains unclear. Previous studies have focused
on the role of Netrin-1 and Netrin-4 in angiogenesis, with
conflicting results. It has been reported that Netrins stimu-
late cell proliferation and migration in primary EC cultures
[12,13] and in VSMC [14]. These pro-angiogenic effects
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have been shown to be independent of cognate Netrin
receptor expression on EC [12,13] with Neogenin as
the only receptor involved in VSMC Netrin signaling [14].
However, Netrins also act as anti-angiogenic factors modu-
lating the response of EC to VEGF [15-17]. Netrin-4 is
anti-angiogenic, inhibiting EC functions through binding to
Neogenin and recruitment of Unc5B [17]. Netrin-4 can also
cause filopodial retraction of EC in vivo [15]. Netrin-1 has
also been shown to inhibit postnatal sprouting angiogenesis
and neovascularization via the activation of the Unc5B
receptor [16]. In addition, overexpression of Netrin-1 or
Netrin-4 by tumor cells delays tumor angiogenesis in
various animal models [16-19].
Netrin-4 is expressed in all ocular tissues and contrib-
utes to angiogenesis in the retina [20,21]. In particular, it
is a prominent protein of vascular basement membranes
where it appears to be tightly associated with pericytes.
Characterization of null mice retinal phenotypes demon-
strated a role for Netrin-4 as a negative regulator of vascu-
lar branching [20]. Little is known about the role of Netrins
on VSMC, EC–pericyte interactions and the formation of
the basement membrane (BM).
The composition and assembly of the vascular basal
lamina plays a key role in vascular tube maturation and
stabilization [22]. Both EC and pericytes induce the ex-
pression of basement membrane components, thus con-
tributing to extracellular matrix synthesis, deposition
and remodeling. Netrin-4 localizes to basement mem-
branes [23] and to the vascular basal lamina, where it in-
teracts with components of the extracellular matrix such
as laminins and integrins [23-25]. Netrin-4 is secreted by
both EC [17] and VSMC (this study). EC–pericyte inter-
actions may be important for the assembly of the base-
ment membrane and for the biological functioning of
blood vessels. There is evidence that a deficit in vascular
basal lamina components influences tumorigenesis [26,27].
Basement membrane abnormalities and lack of pericyte
coverage are also frequently observed in the retina of
patients with diabetic retinopathy [28]. To clarify the
mechanisms by which Netrin-4 inhibits angiogenesis and
reduces tumor growth, we examined the effects of Netrin-4
on VSMC in vitro and on tumor angiogenesis.
Materials and methods
Cell culture
VSMC were isolated from human umbilical cord blood as
previously described [29]. Briefly, mononuclear cells were
obtained from umbilical blood by Ficoll separation. Cells
were allowed to pre-adhere overnight on a culture dish
and then fibroblasts were discarded. The remaining adher-
ent cells were re-suspended, washed and cultured in
M199 medium, supplemented with 20% FCS and 10 ng/ml
VEGF in 6-well plates coated with rat tail collagen I. The
medium was changed twice a week. After 3–4 weeks, the
VSMC clones were collected and expanded. VSMC identity
was confirmed by alpha smooth muscle actin immuno-
staining [29]. Human Umbilical Arterial Endothelial Cells
(HUAEC) from the same donors were isolated by collage-
nase dissociation (Roche Diagnostic). EC were cultured in
EBM (Clonetics) supplemented with 10% FCS and 2 ng/ml
of VEGF. The medium was changed every 4 days. Their
EC origin was confirmed by von Willebrand Factor (vWF)
staining. Primary Porcine Retinal Pericyte cells (PRPC)
were cultured in DMEM supplemented with 15% FCS.
Wound migration assays
The IncuCyte live-cell imaging system was used for cell
migration assays (Essen BioScience). Cells were grown
to confluence in 96-well or 24-well Essen Bioscience
plates previously coated with 0.2% Gelatin (Sigma). The
culture plates were loaded into the wound maker tool,
which creates precise and reproducible wounds in all
wells. Plates were washed twice with culture medium
and then incubated in medium with or without human
recombinant Netrin-4 (R&D; 50 ng/ml. Each plate was
then placed inside the IncuCyte and kinetic images were
taken every 2 hours for 24 h. IncuCyte software was used
to quantify cell migration.
Proliferation cell assay
The number of living cells was spectrophotometrically
measured using an MTT assay. Cells were seeded onto
culture plates previously coated with 0.2% gelatin and
grown in their regular medium. The next day, cells were
stimulated with the indicated concentrations of Netrin-4
(recombinant human Netrin-4 from R&D). Twenty
four hours later, cells were washed once with PBS and
incubated at 37°C in 5% CO2 in a solution of MTT
(Sigma; 1 mg/ml in PBS). After 2 hours, isopropanol (50%)
was directly added to the MTT solution and plates were
gently mixed using a plate shaker. The absorbance was dir-
ectly measured at 570 nm in a microplate reader. Data were
analysed using Excel software.
Cell adhesion assay
Cell adhesion assays were performed as previously de-
scribed [30]. The wells of 96-well Maxisorp plates (Nunc)
were coated overnight at 37°C with either 1% BSA (Bovine
serum Albumin, Sigma), 2.5 μg/ml human Vitronectin
(R&D) or recombinant human Netrin-4 (R&D) diluted in
PBS. After two washes in PBS, non-specific binding sites
were blocked for 1 hour at 37°C using 1% BSA. After
washes with PBS and water, 100 μl of a cell suspension con-
taining 500000 cells per ml in culture medium was added
(three wells per treatment) to each well and incubated at
37°C for 4 hours. Non-adherent cells were washed off with
water. Cells that adhered to the substrate were fixed and
stained with crystal violet (0.2% in methanol). Images were
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acquired with an inverted microscope (Nikon Eclipse Ti)
equipped with a digital camera. Dye bound to adhered cells
was solubilized with 0.1% SDS and the absorbance at
560 nm was measured. The data reported were mean
values of the three determinations per treatment.
HUAEC and VSMC co-cultures on Matrigel
The in vitro angiogenesis assay was performed according
to a previously published protocol [31].
Briefly, 24-well cell culture plates were coated with
Matrigel Basement Membrane Matrix (BD Biosciences, Le
Pont de Claix France). The culture plates were incubated at
37°C for at least 30 minutes to allow the basement mem-
brane to form a gel. HUAEC were labeled with SP-Dioc18
(3,3’-dioctadecyl-5-5’-di(4-sulfophenyl) oxacarbocyanine,
Invitrogen) green dye (2 μg/ml) and VSMC were labeled
with CM-Dil red dye (1 μg/ml) (Invitrogen). HUAEC were
added on top of the Matrigel matrix (3.104 per well) and
then incubated overnight in EBM 10% FCS to induce
tube formation. VSMC were then added to the endothe-
lial network (1.5×104 VSMC per well) and the samples
incubated for 5 hours. Cells were visualized by inverted-
phase fluorescence microscopy (Zeiss, Le Pecq, France).
Photographs of ten representative fields were taken and
quantified using Histolab software (Microvision, Evry).
Statistical analyses were performed using either Student’s t
test or ANOVA.
Small interfering RNA and transfection assays
Subconfluent cells were transfected with a mixture of
3 μl/ml TransIT-KO transfection reagent (Mirus) and
50 nM siRNA diluted in serum free culture medium,
according to the manufacturer’s protocol. siRNA target-
ing different sequences in the human netrin-4 gene were
obtained from Qiagen (NTN 1–4). Two sets of 4 prede-
signed siRNA (SMARTpool, Dharmacon) were used to
silence DCC and Unc5b gene expression. Two silencer
validated neogenin siRNAs were purchased from Ambion
(Autin, TX). Different siRNAs were used as controls: the
siCONTROL non-targeting siRNA from Dharmacon and
the Stealth RNAi negative control from Invitrogen.
RT-PCR analysis
Total cellular RNA was isolated using the RNeasy mini
kit (Qiagen) following the manufacturer's instructions. The
first strand cDNA template was synthesized from 0.5 μg of
total RNA using the Superscript II Reverse Transcriptase
synthesis kit and random hexamer primers (Invitrogen).
The cDNA product was amplified using the Taq DNA
polymerase mix (Invitrogen) and a Px2 thermal cycler
apparatus. The primers used for PCR are given in Table 1.
Amplified products were analyzed on a 2% agarose gel
with ethidium bromide staining. The mRNA levels were
normalized to beta Actin mRNA.
Quantitative reverse transcription PCR
The cDNA product was amplified using Power SYBR
Green PCR Master Mix (Applied Biosystems, France) and
a Light Cycler 1.5 apparatus with the primers described in
Table 1. Standard curves for each mRNA were generated
by serial dilutions of cDNA synthesized from total RNA
isolated from human fetal brain tissue.
Transfection of PC3 prostate carcinoma cells and
xenograft in nude mice
Transfection of PC3 cells and mouse xenografts was
performed as previously reported [17]. Briefly, different
clones of PC3 cells overexpressing Netrin-4 were estab-
lished and characterized. Female, athymic, nude mice were
randomized (eight per group) and injected subcutaneously
with 2 × 106 PC3 cells transfected with either Netrin-4 or
empty vector pcDNA3.
Intravital microscopy
Intravital microscopy was performed with a Cellvizio®
(Mauna Kea Technologies) Leica FCM1000. This device
combines confocal fluorescence microscopy with an optical-
fiber miniprobe (1.5 mm diameter, 488 nm excitation wave-
length), which collects light (505–700 nm wavelength) from
the observation site and conveys it to a dedicated imaging
device. Cellvizio® can explore microvascularization of de-
nuded tumors in their native environment with limited
invasiveness and preservation of the physiological state
of tissues. Mice were anesthetized with 75 mL/kg of a
solution of 5% xylazine (Rompum 2%) and 20% ketamine
(Imalgene 500). Animal body temperature was maintained
using a heating plate. Fluorescein isothiocyanate-dextran
500 kDa (FD-500S, Sigma Aldrich®, 35 mg/kg) was injected
intravenously (retro-orbitary injection) to visualize blood
vessels. The excitation maximum of FITC-dextran is
490 nm and the emission maximum is 520 nm. Videos
and images of tumor angiogenesis were obtained using
the Cellvizio® software, ImageCell™.
Immunohistochemistry
Netrin-4 in VSMC was detected after fixation in 4%
PFA followed by addition of 0.1% Triton. An antibody
against human Netrin-4 (R&D) was detected with Alexa
Fluor-labelled anti-goat secondary antibody (Molecular
Probes, 2 μg/μl). Cells were observed using an inverted
fluorescence microscope (Nikon Eclipse Ti) equipped with
a digital camera.
Intratumoral vessels in 10 μm-thick cryostat sections
were detected using rabbit anti-desmin (labvision, 1/200
in PBS 1% triton) and rat anti-CD31 (BD Biosciences) as
primary antibodies. Alexa Fluor 555-labeled donkey anti-
rabbit and Alexa Fluor 488 chicken anti-rat (1:250 dilution,
Invitrogen, Molecular Probes, Eugene, USA) were then
applied as secondary antibodies. Images were acquired
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with an inverted fluorescence microscope (Zeiss, Le Pecq,
France). Desmin staining was quantified at a 20x magnifi-
cation using Image J software. The Mann–Whitney U test
was used for statistical analyses.
Statistical analysis
Microsoft Excel was used for data analysis and graphic
representation. Data were presented as means ± standard
deviation (SD). ANOVA was used for statistical analyses.
P values less than 0.05 were considered statistically signifi-
cant. *P < 0.05, **P < 0.01, ***P < 0.001.
Results
Netrin-4 promotes mural cells migration
We investigated the effect of Netrin-4 on the migration
of mural cells using two independent cell types. First,
a wound-healing assay was performed using primary
Vascular Smooth Muscle Cells (VSMC) isolated from
human umbilical cord blood. Migration of VSMC was
analyzed using an automated wound-healing assay
(IncuCyte technology; Essen BioScience) during a 20-hour
period in which the cells were incubated in the presence
or absence of human recombinant Netrin-4. The addition
of Netrin-4 stimulated VSMC migration (Figure 1A). Sec-
ond, the effect of Netrin-4 on the migration of porcine ret-
inal pericyte cells (PRPC) was measured using the same
experimental system. The presence of 50 ng/ml of Netrin-
4 increased the migration of PRPC (Figure 1B). In both
cell types, the addition of Netrin-4 stimulated migration;
however, the effect of cell proliferation was unknown.
A MTT cell proliferation assay indicated that addition
of Netrin-4 did not increase cell proliferation after 24
hours (Additional file 1: Figure S1).
Netrin-4 promotes VSMC adhesion
To determine the effect of Netrin-4 on VSMC adhesion,
96-well plates were coated with the recombinant human
Netrin-4 protein (R&D), BSA (as a negative control) or
Vitronectin (as a positive control). VSMC were allowed
to adhere and spread for 4 hours and were then sta-
ined with crystal violet. The cells in wells coated with
Vitronectin adhered (Figure 2A) and spread (Figure 2C),
but cells on BSA did not adhere (Figure 2A). VSMC grown
on Netrin-4-coated wells were adherent (Figure 2A) and
showed a clear spreading of cells (Figure 2D). Measure-
ment of dye absorbance confirmed these observations
(Figure 2B). These results demonstrated that VSMC
adhered to the Netrin-4 protein.
VSMC express Netrin-4 and three of the six known
Netrin receptors
We examined the expression of Netrin-4 and the six known
Netrin receptors using VSMC from two different human
donors and from Cambrex. Using quantitative real-time
PCR, we detected mRNA encoding Netrin-4 and three
Netrin receptors; DCC, Neogenin, and Unc5B, (Figure 3).
Expression of Unc5A, Unc5C and Unc5D was not detected.
Expression was measured as the amount of transcript
relative to Actin and compared with transcript quantities
present in human fetal brain (normalized to 1; Figure 3).
We observed that DCC and Neogenin transcript levels
were lower in VSMC compared with transcripts isolated
from fetal brain tissue. In contrast, Netrin-4 transcript
levels were higher in VSMC compared with transcripts
isolated from fetal brain tissue (Figure 3). In contrast, in
VSMC, the level of the Unc5B transcript was similar to
that measured in the fetal brain (Figure 3; Additional file 2:
Figure S2A).
The presence of Netrin-4 in VSMC was further con-
firmed by immunocytochemistry. VSMC were fixed and
stained with a specific antibody that recognizes the hu-
man Netrin-4 protein (R&D). Endogenous Netrin-4 was
found distributed throughout the cytoplasm of VSMC
(Figure 4A). To visualize a possible interaction between
VSMC and exogenous Netrin-4, cells were incubated for
2 hours with the recombinant human protein (R&D).
Netrin-4 immunostaining revealed Netrin-4 specifically
localized on the cell surface and along cell processes
(Figure 4B). Because Netrin-4 is a secreted protein,
ELISA assays were performed on VSMC after transfec-
tion of empty vector or plasmid encoding Netrin-4 to
determine whether VSMC secrete Netrin-4. Expression
Table 1 Primers used for RT-PCR and qPCR
Name Accession number Forward primer Reverse primer
Neogenin 62U612 5'-TCGCTGCGTAGTGGAAAGTG-3' 5'-CTGTGTCAAGTGCCTCCTCA-3'
DCC X76132 5'-ACTTGGGGTGGTGAAGTCAG-3' 5'-CCAAGACAGGGACCACATCT-3'
Unc5A AK131380 5'-CATCGAGTGCTTTGAGGTGA-3' 5'-ACCTGCTGCCTTGAGACATT-3'
Unc5B AY126437 5'-ACTCATCTGCTGCCCTGACT-3' 5'-ATTTTGTCGGTGGAGTCCTG-3'
Unc5C AF055634 5'-CACTGCACCTTCACTCTGGA-3' 5'-GAGAGGGATGCTGAAAGCAC-3'
Unc5D AB055056 5'-GGTGCTCCTGAGTCCTGAAG-3' 5'-GGGTCCAAAAGGCAGTAACA-3'
Netrin 4 AF278532 5'-CAGACATAGACTGGTGTCATGAAGTT-3' 5'-ACATTGACCTCAACATGAGTACCTT-3'
Beta actin X00351 5'-AGAGCTACGAGCTGCCTGAC-3' 5'-AGCACTGTGTTGGCGTACAG-3'
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of Netrin-4 in transfected cells was visualized by immuno-
cytochemistry (Figure 4C). Detection of the protein in
VSMC conditioned media indicated that Netrin-4 was
secreted from VSMC (Figure 4D).
Netrin-4 induces VSMC adhesion via DCC, Neogenin and
Unc5B receptors
To determine which Netrin receptor expressed on VSMC
mediated the observed response to Netrin-4, expression
of the DCC, Neogenin and Unc5B Netrin receptors was
silenced using siRNA in VSMC. Silencing was verified
by RT-PCR 24 hours after transfection (Additional file 2:
Figure S2B). Cell adhesion assays were performed two
days after siRNA transfection as described in Figure 2.
Transfected VSMC were allowed to adhere to BSA,
Vitronectin or Netrin-4 coated culture wells. Transfected
VSMC adhered to Vitronectin (Figure 5A) and Netrin-4
(Figures 5B, C, D, and E). Knocking-down DCC, Neogenin
or Unc5B expression did not change the adhesion capacity
of VSMC to Vitronectin (Figure 5F); however, silencing
DCC, Neogenin or Unc5B receptors significantly reduced
VSMC adhesion to Netrin-4 (Figure 5F), suggesting that
all three receptors are involved in this process.
Netrin-4 enhances VSMC recruitment in an in vitro model
of endothelial cell-pericyte interaction
Netrin-4 was shown to inhibit the ability of HUAEC to
form vascular networks on Matrigel [17]. To investigate
the effects of Netrin-4 on VSMC and their interaction with
EC, we used a co-culture model of HUAEC and VSMC
plated on Matrigel. HUAEC were plated on Matrigel
and allowed to form vascular networks for 24 hours.
VSMC were then added and were left in contact with
HUAEC for five hours. Two experiments were performed
using this HUAEC-VSMC co-culture assay. First, we pre-
treated VSMC with exogenous Netrin-4 for 24 h prior to
co-culture with HUAEC. This pre-treatment significantly
increased the percentage of HUAEC coverage by VSMC
(Figure 6A). Second, expression of Netrin-4 in VSMC was
silenced by siRNA to investigate the role of Netrin-4 in
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Figure 1 Netrin-4 promotes Mural cell migration. Time course of Vascular Smooth Muscle Cell (A) and Porcine Retinal Pericyte Cells (B)
migration with and without the addition of Netrin-4 (R&D; 50 ng/ml). Cells were grown to confluence in complete medium and wounds were
made. Cells were treated (N4) or not (Control) with the human recombinant protein Netrin-4 (50 ng/ml) and allowed to migrate for 20 hours.
Data were collected and analyzed on IncuCyte. Compared to controls, treatment with Netrin-4 stimulates VSMC (A) and PRPC (B) migration.
Statistical analysis of data at t = 10 h and t = 20 h showed that Netrin-4 significantly increased VSMC (A) and PRPC (B) migration.
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Figure 2 Adhesion of cultured VSMC to Netrin-4. (A) Crystal violet staining of cells that adhered to the substrate. 96-well plates were coated
overnight with BSA, Vitronectin (VN; 2.5 μg/ml) or Netrin-4 (N4, 1 μg/ml). VSMC were added to the wells and incubated for 4 hours at 37°C. BSA
was used as a negative control and Vitronectin (VN) was used as a positive control. VSMC adhere to Netrin-4 (N4) or Vitronectin but not to BSA.
(B) Quantification of cell adhesion with the three substrates by measurement of absorbance. All assays were performed in triplicate in at least
three different experiments. (C) Contrast phase image of VSMC adhesion in the presence of Vitronectin, 20x magnification (D) Contrast phase
image of VSMC adhesion in the presence of Netrin-4, 20x magnification. Scale bar: 50 μm.
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Figure 3 Expression of Netrin-4 and Netrin receptors in VSMC. Quantitative RT-PCR analysis of VSMC to assay Netrin-4 and Neogenin, DCC,
and Unc5B receptor mRNA expression. Expression values were normalized to that of Actin and are reported relative to that in human fetal brain
(normalized to 1).
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mural cell recruitment. RT-PCR analysis confirmed a
specific down-regulation of Netrin-4 expression in VSMC
transfected with a siRNA targeting Netrin-4 (Figure 6B).
This silencing of Netrin-4 in VSMC significantly re-
duced their coverage of HUAEC (Figure 6B) implicating
endogenous Netrin-4 expression by VSMC in adhesion
of VSMC on EC.
Overexpression of Netrin-4 by PC3 cells increases mural
cell coverage in tumor vasculature
We previously reported that Netrin-4 overexpression in
PC3 cells delayed tumor uptake and growth. These Netrin-
4 anti-tumor properties were attributed to direct effects on
endothelial cells [17]. Here, we investigated the role of
Netrin-4 in vessel maturation using the same in vivo
model. Tumor blood vessel maturation was assessed in
nude mice subcutaneously xenografted with human PC3
(prostate cancer) cells overexpressing Netrin-4. Intravital
microscopy analysis of the morphology of intratumoral
vasculature revealed that empty vector-transfected tumors
were supplied by highly tortuous, disorganized vessels
(Control, Figure7A). In Netrin-4 transfected tumors,
vessels displayed structure and hierarchical organization
more similar to that of the microvascular network of
healthy tissues (Netrin-4, Figure 7A). Immunohistochemi-
cal analysis of tumor sections with an antibody specific for
desmin, a marker of perivascular cells, was used to evaluate
the effect of Netrin-4 transfection on the tumor vasculature
at the cellular level. The number of desmin-positive cells
per slide was significantly higher in Netrin-4 transfected
samples compared with controls (Figure 7B). Moreover,
double immunostaining with the endothelial marker CD31
showed colocalization with desmin staining (Figure 7B)
indicating that Netrin-4 enhanced the recruitment of
perivascular cells on tumor EC.
Our in vivo findings suggested that Netrin-4 overexpres-
sion induced tumoral vessel maturation by recruiting more
perivascular cells.
Discussion
In the current study, we have investigated the role of
Netrin-4 in VSMC during normal and pathological angio-
genesis. In vitro analyses showed that Netrin-4 promotes
VSMC migration and adhesion via DCC, Neogenin and
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Figure 4 Immunolabelling of endogenous and exogenous Netrin-4 in VSMC. Cells were fixed and stained with an antibody against Netrin-4.
(A) Immunolabelling of endogenous Netrin-4 within the cytoplasm of VSMC. (B) VSMC were incubated with exogenous Netrin-4 for 2 hours.
Netrin-4 immunoreactivity is at the cell surface suggesting that the Netrin-4 is bound to the Netrin receptors. Scale bar: 100 μm. (C & D) Cells
were transfected with empty vector (pcDN3.1) or with Netrin-4 expressing plasmid (pcDN3.1-N4). Two days after transfection, conditioned media
were collected and cells were fixed. As observed in C, transfected cells express Netrin-4. Scale bar: 200 μm. (D) Detection of the protein in the
conditioned media by ELISA showing that Netrin-4 is secreted by VSMC.
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Unc5B receptors. Silencing of Netrin-4 in VSMC resulted
in a significant reduction in their association with EC
tubes. Netrin-4 overexpression in a model of subcutane-
ous PC3 cell xenograft increased the recruitment of mural
cells to tumor vessels.
Netrin-4 promotes the recruitment of VSMC on EC-lined
tubes formed in vitro
Angiogenesis is regulated by interactions between endothe-
lial, mural and stromal cells with the extracellular matrix
[32,33]. In addition, interactions between the cell types, EC
N
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Figure 5 DCC, Neogenin and Unc5B are required for Netrin-4-induced VSMC adhesion. VSMC were transfected with a control non-specific
siRNA (control; A & B) or a specific siRNA targeting the DCC (C), Neogenin (D) or Unc5B (E) receptors. Contrast phase images indicate that
transfected VSMC adhered to Vitronectin (A) and to Netrin-4 (B-E). Scale bar: 150 μm. (F) Quantification of cell adhesion to the three substrates
by measurement of absorbance under the four experimental conditions. Silencing of DCC, Neogenin or Unc5B significantly decreased VSMC
adhesion to Netrin-4, implicating these three receptors in the process.
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and VSMC, are critical for the formation, maturation and
maintenance of blood vessels (as reviewed in [1,2]); there-
fore, angiogenesis modulators should be assessed in both of
these cell types. Netrin-4 is secreted by both EC and VSMC
and so may act on different targets, involving each cell type
separately, as well as acting on their interactions. We have
previously demonstrated that Netrin-4 inhibits HUAEC
proliferation and migration as well as their ability to form
tubular structures on Matrigel [17]. Here, our findings
clearly indicate that Netrin-4 influences in vitro VSMC
recruitment to EC-lined tubes formed on Matrigel. Because
silencing Netrin-4 expression in VSMC reduces their cover-
age on EC, our data indicate that endogenous Netrin-4
produced by VSMC is important for their recruitment.
These data suggest that Netrin-4 secreted by VSMC may
be required for their interaction with EC through Netrin
Control
N4
Control N4 
siRNA 
NT
N4
SiRNA
Control
SiRNA
N4
Actin
A
B
*
*
VS
M
C/
EC
VS
M
C/
EC
Figure 6 Netrin-4 enhances VSMC recruitment on HUAEC in vitro. (A) Co-culture of VSMC (stained in red) and HUAEC (stained in green)
grown on Matrigel indicated that pericyte coverage was greater with VSMC pretreated with Netrin-4 (N4) compared with non-treated cells
(Control). (B) Silencing of Netrin-4 expression in VSMC using siRNA significantly reduced HUAEC coverage by VSMC (arrows). RT-PCR analysis
showed that N4 expression is down-regulated in VSMC transfected with Netrin-4 siRNA (N4siRNA), but not in non-transfected (NT) cells or in
VSMC transfected with a control siRNA (Control siRNA). A Student’s t test was used to assess the statistical significance of differences between
groups **P < 0.01, *P < 0.05.
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receptors. Because VSMC express DCC, Neogenin and
Unc5B receptors, Netrin-4 may also affect VSMC in a cell
autonomous manner. Further experiments such as silen-
cing receptor expression in the co-culture assay will be
necessary to better understand Netrin-4 mechanism of ac-
tion. Moreover, pre-treatment of VSMC with exogenous
Netrin-4 increased EC coverage, suggesting that Netrin-4
produced by EC or stored in ECM may also play a role in
VSMC recruitment.
Stratman et al. reported that EC are required to induce
pericyte motility in a 3D collagen matrix and that EC
production of PDGF and EGF regulates pericyte cover-
age [34,35]. Here, we show that Netrin-4 enhances
VSMC migration, adhesion and association to EC net-
works on Matrigel. Both VSMC and EC produce
Netrin-4 and express Netrin-4 receptors, which have
been shown to mediate VSMC adhesion and migration
(Additional file 2: Figure S2C). Because silencing all
three Netrin VSMC receptors does not completely inhibit
adhesion to Netrin-4 (data not shown), other receptors,
such as integrins [36-39], may also be involved. Specific
intercellular signals are required to mediate the EC-pericyte
interaction [40]. Thus, the Netrin-4 pathway (Netrin-4 and
its receptors present on EC and VSMC) may play an im-
portant role in this endothelial-pericyte communication.
Netrin-4 may recruit mural cells as a component of the
vascular BM
Interaction of EC and perivascular cells with the base-
ment membrane (BM) also plays an important role dur-
ing the angiogenic processes [22]. EC and pericytes both
contribute to basement membrane composition, deposition
and assembly. ECM components influence the behavior of
EC and perivascular cells. BM components appear to be as
guiding cues for pericytes that extend cellular processes to
contact EC [35]. Genetic ablation of Neuron-glial proteo-
glycan 2 (NG-2), a cell surface component of pericyte, im-
pairs the interaction between EC and pericytes, which leads
to reduced pericyte attachment and assembly of the vascu-
lar basal lamina. Further analysis of neovessels in NG2 null
mice revealed changes in components of the basal lamina
including loss of collagen VI and reduced collagen IV de-
position [41]. Thickening of the basement membrane and
selective loss of pericytes are early events of human diabetic
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Figure 7 Netrin-4 induces mural cell coverage of tumor vessels in vivo. (A) Intravital microscopy of subcutaneous PC3 tumors (Control) and
those overexpressing Netrin-4 (Netrin-4). The organization of blood vessels in Netrin-4 overexpressing tumors was better structured than in control
tumors. Imaging probe field: 400 × 300 μm. (B) Desmin (red) and CD31 (green) immunostaining on tissue sections of four different tumors from
Netrin-4 transfected (Netrin-4) and empty vector transfected PC3 (Control) groups. Fields were examined by immunofluorescence microscopy, data
were analyzed by Image J software and results expressed as mean pixels per μm2 (20 fields per condition). A Student’s t test was used to assess the
statistical significance of differences between groups *P < 0.05. Desmin staining was significantly greater in Netrin-4-overexpressing tumors (graph in B)
and co-localized with CD31 immunostaining (merge: Desmin/CD31) indicating that Netrin-4 promotes VSMC coverage of tumor vessels.
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retinopathy [28]. Thus pericyte adhesion and formation of
the perivascular matrix seem to be linked and play essential
roles for vascular stability.
In vessels, the BM is mainly composed of four types of
molecules including laminin, collagen, perlecan and nido-
gen [42]. Netrin-4 is structurally similar to laminin beta
chains and is often deposited in basement membranes.
Netrin-4 is a component of the vascular basal lamina [23]
and has been reported to interact with laminins [24].
Laminins are a major family of ECM molecules and play
an important role in basement membrane assembly in
angiogenesis [42]. Binding of Netrin-4 to laminin γ1 short
arms inhibits laminin self assembly [24]; Netrin-4 may
act through interaction with basement membrane compo-
nents such as laminin, which can then influence signaling
to EC and mural cells.
Netrin-4 promotes mural cell recruitment on tumor
blood vessels
Most studies have focused on the role of EC in tumor
angiogenesis; however, pericytes are commonly involved
in tumor angiogenesis. As such, there is currently inter-
est in their potential as targets for cancer therapies
[3,43]. There are only a few reports on the expression of
Netrin-4 in human cancer [44-46] although Netrin-4 has
been recently identified as a gene up-regulated in 37.5%
of breast cancers and its expression is correlated with
longer overall survival [45]. We reported previously that
Netrin-4 overexpression in pancreatic tumor cells (PC3)
[17] and in colon cancer cells (LS174) [18] delayed tumor
angiogenesis in two mouse models of subcutaneous xeno-
graft. These properties were first attributed to direct effects
on endothelial cells. Here, we addressed the role of
Netrin-4 on mural cells using the same PC3 model.
Double Desmin/CD31 immunostaining of tumor sections
shows that Netrin-4 overexpression in PC3 cancer cells
increases coverage of tumor vasculature. However, further
characterization of these desmin positive cells would
be necessary to confirm the identity of these perivascu-
lar cells. Furthermore, intravital microscopy analysis of
tumors shows that Netrin-4 overexpression correlated
with vessel normalization.
Taken together, our in vivo findings suggest that Netrin-4
overexpression induces tumor vessel maturation by recruit-
ing more perivascular cells. In this model, the main source
of Netrin-4 is provided by the transfected PC3 tumor cells,
which secrete the protein. Thus, our results suggest that
it is the secreted Netrin-4 that promotes the recruitment
of mural cells on the nascent vasculature, contributing to
blood vessel maturation and stabilization. This is also sup-
ported by our in vitro observation that Netrin-4 enhances
the EC coverage by VSMC. Overexpression of Netrin-4
may also mediate tumor vascular normalization through its
actions on the vascular basement membrane and inhibitory
effects on EC. As observed in a recent model of corneal
neovascularization, Netrin-4 may also induce tumor blood
vessels normalization through down-regulation of VEGF
[47]. Finally, overexpression of Netrin-4 could restore
the balance between pro-and anti-angiogenic signaling.
The in vivo analysis also suggests that maturation of
the tumoral vasculature induced by Netrin-4 may be
responsible for the reduced tumor growth in vivo.
Overexpression of PDGF-BB in pancreatic and colorectal
cancer cells leads to an increase in pericyte recruitment to
the tumor vasculature, which in turn slows down tumor
growth [48]. Pericyte recruitment is essential for the devel-
opment of the tumor vasculature, and is dependent on vari-
ous angiogenic factors. There are two possible strategies for
anti-tumoral therapies targeting angiogenesis. Increasing
the number of pericytes may stabilize and normalize blood
vessels, thereby restricting vessel sprouting and tumor
growth. Alternatively, limiting pericyte coverage may also
lead to destabilization and collapse of the vasculature.
Both strategies induce tumor regression [3,33]. Promoting
pericyte coverage of tumor vessels may not only prevent
vessel sprouting and tumor uptake but may also allow
more effective intratumoral delivery of chemotherapy.
Therefore, normalization of tumor vessels may be valuable
for anti-angiogenic therapy [49]. A recent study supports
this view: a blockade of the TGF-beta signaling pathway in-
creased pericyte recruitment and incorporation into tumor
vasculature. Normalization of tumor blood vessels reduced
cancer progression in terms of tumor growth and metasta-
sis, suggesting improved drug delivery and efficacy [50].
In addition to tumor pericyte coverage, the degree of
pericyte involvement may influence the dynamics of tumor
growth. Abnormal pericyte integration may be responsible
for vessel defects that contribute to metastasis. Defects in
pericyte coverage of the tumor vasculature are associated
with an increase in the number of metastases in several
mouse models of cancer [3]. Netrin-4 overexpression
decreases colorectal cancer progression in terms of liver
metastasis number and size [51]. Finally, tumor blood
vessels normalization may represent a mechanism that
interferes with tumor growth. Thalidomide is an anti-
tumor and anti-angiogenic factor whose properties were
attributed to direct effects on endothelial cells. Inter-
estingly, a recent study demonstrated that thalidomide
also promotes vessel maturation by enhancing pericyte
coverage, suggesting that therapeutic effect of this
compound might be the result of inhibition of endo-
thelial cells as well as of direct stimulation of mural
cells recruitment [52].
In conclusion, Netrin-4 appears to stimulate mural cell
recruitment (this study) and limit EC proliferation [17].
We propose that Netrin-4 acts as an anti-angiogenic
factor through the regulation of both endothelial and
perivascular cells.
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Endnotes
Non standard abbreviations used
VSMC: vascular smooth muscle cells; EC: endothelial
cells; HUAEC: Human Umbilical Arterial Endothelial
Cells; N4: Netrin-4; ECM: extracellular matrix; BM:
basement membrane.
Additional files
Additional file 1: Figure S1. Netrin-4 does not stimulate mural cell
proliferation: MTT cell proliferation assay of Vascular Smooth Muscle Cells
(A) and Porcine Retinal Pericyte Cells (B) incubated for 24 hours with or
without Netrin-4. Serum free condition was used as a negative control
and cells incubated in their complete growth medium (Control) was used
as a positive control. Netrin-4 (N4) was added to the complete medium
at the indicated final concentration. Addition of Netrin-4 did not
stimulate cell proliferation. No significant differences were observed
between the control and the Netrin-4 conditions thus indicating that
Netrin-4 does not influence cell proliferation.
Additional file 2: Figure S2. (A) RT-PCR analysis of Netrin-4 and Netrin
receptors in human VSMC and fetal brain. VSMC Netrin-4 and UNC5B
transcript levels are similar compared with those of measured in the fetal
brain; however, expression of Neogenin and DCC receptors was lower in
VSMC compared with the brain. (B) RT-PCR analysis of Netrin receptors
after siRNA transfection: Cells were transfected with either Control (Ctrl),
DCC, Neogenin (Neo) or UNC5B siRNAs. Expression of Netrin receptors
and Actin was measured via RT-PCR analysis in the four different
conditions. Actin was expressed in all samples. Expression of Unc5B was not
detected in cells treated with siRNAs targeting UNC5B. Neogenin and DCC
expression was down-regulated in the cells transfected with the
corresponding siRNA. (C) Effect of Netrin receptors invalidation on VSMC
migration: Time course migration of non-transfected cells (NT) and cells
transfected with the control siRNA (Control) or with a SiRNA targeting a netrin
receptor (DCC, Neogenin and Unc5B). After 30 hours post-transfection, cells
were allowed to migrate for 18 h in the presence of 50 ng/ml of Netrin-4.
Compared with the control, N4-induced migration of VSMC was decreased
when the DCC or Neogenin receptor expression was decreased, thus
implicating these receptors in the process.
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